• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿ LONG; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿ LONG; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911338300
Device Problem Occlusion Within Device (1423)
Patient Problems Reocclusion (1985); Pain (1994); Thrombosis (2100)
Event Date 06/13/2014
Event Type  Injury  
Event Description
Same case as mdr id# 2134265-2015-03666, 2134265-2015-03667 and 2134265-2015-03669.(b)(4).It was reported that very late stent thrombosis occurred.In (b)(6) 2013, the patient was referred for cardiac catheterization which revealed four (4) target lesions.Target lesion #1 was located in the proximal right coronary artery (rca) extending into distal rca with 75% stenosis, and was 28mm long with a reference vessel diameter of 4.0 mm.Target lesion #1 was treated with pre-dilatation and placement of a 4.00 x 28mm study stent.Following intervention, residual stenosis was 0%.Target lesion #2 was located in the proximal rca extending into distal rca with 80% stenosis, and was 32mm long with a reference vessel diameter of 4.0 mm.Target lesion #2 was treated with pre-dilatation and placement of a 4.00 x 32mm study stent.Following intervention, residual stenosis was 0%.Target lesion #3 was located in the proximal rca extending into distal rca with 100% stenosis, and was 38mm long with a reference vessel diameter of 3.0mm.Target lesion #3 was treated with pre-dilatation and placement of 3.00 x 38mm study stent.Following intervention, residual stenosis was 0%.Target lesion #4 was located in the proximal rca extending into distal rca with 100% stenosis, and was 24mm long with a reference vessel diameter of 2.5mm.Target lesion #4 was treated with pre-dilatation and placement of 2.50 x 24mm study stent.Following intervention, residual stenosis was 0%.Seven days post index procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2014, the patient presented with cardiac pain and was hospitalized.Four days post admission, coronary angiography revealed 80% stent thrombosis of the previously placed study stent from the proximal rca to the distal rca.On the same day, the patient was treated with percutaneous coronary intervention (pci).Following intervention, residual stenosis was 0%.Two days post intervention the event was considered as recovered/resolved and the patient was discharged on the same day.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that on (b)(6) 2015, in-stent restenosis occurred and was not stent thrombosis as what was previously reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT ¿ LONG
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
ballybrit business park
galway
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4824789
MDR Text Key5904528
Report Number2134265-2015-03668
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCN
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative,company represent
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/14/2014
Device Model NumberH7493911338300
Device Catalogue Number39113-3830
Device Lot Number15808649
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/21/2015
Initial Date FDA Received06/08/2015
Supplement Dates Manufacturer Received09/19/2017
Supplement Dates FDA Received10/05/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/27/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age29 YR
-
-